Company Search:
Advanced Search
Sponsored Links
Takeda Pharmaceutical Company Limited Company Snapshot
Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other companies in this sector in Japan: Eisai Company Limited (2019 sales of 642.83 billion Japanese Yen [US$5.92 billion] of which 88% was Pharmaceutical Business), Astellas Pharma Incorporated (1.31 trillion Japanese Yen [US$12.03 billion] of which 97% was Sales of Pharmaceuticals), and Daiichi Sankyo Company Limited (929.72 billion Japanese Yen [US$8.56 billion] of which 93% was Prescription drugs).

Sales Analysis. Takeda Pharmaceutical Company Limited reported sales of ¥2.10 trillion (US$19.32 billion) for the fiscal year ending March of 2019. This represents an increase of 18.5% versus 2018, when the company's sales were ¥1.77 trillion. Sales of Pharmaceutical Business saw an increase of 19.6% in 2019, from ¥1.69 trillion to ¥2.03 trillion. Not all segments of Takeda Pharmaceutical Company Limited experienced an increase in sales in 2019: sales of Intellectual Property and Service Revenu fell 7.5% to ¥70.95 billion. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Takeda Pharmaceutical Company Limited
  Stock Performance Chart for Takeda Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 4,455.00
(Figures in Japanese Yen)
1 Week 0.1%   13 Weeks 11.4%  
4 Weeks 24.1%   52 Weeks 4.7%  
Takeda Pharmaceutical Company Limited Key Data:
  Ticker: 4502 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 2,097,224,000,000
(Year Ending Jan 2020).
Employees: 49,578
  Currency: Japanese Yen Market Cap: 6,939,761,201,010
  Fiscal Yr Ends: March Shares Outstanding: 1,557,746,622
  Share Type: Common Closely Held Shares: 20,820,662
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.